Try our mobile app

Published: 2022-11-17 17:09:35 ET
<<<  go to CLX company page
0000021076 false false 0000021076 2022-11-15 2022-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

___________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  November 16, 2022

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)

___________________
 

Delaware

      

1-07151

     

31-0595760

(State or other jurisdiction of
incorporation)

(Commission File Number)

(I.R.S. Employer
Identification No.)

 

1221 Broadway, Oakland, California

   

94612-1888

(Address of principal executive offices)

(Zip code)

 
(510) 271-7000
(Registrant's telephone number, including area code)
 
Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]

Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

 
[ ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
[ ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
[ ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Name of each exchange on which registered
Symbol(s)
Common Stock - $1.00 par value CLX New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company            ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.            ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

On November 16, 2022, The Clorox Company (the “Company”) held its virtual annual meeting of shareholders. The matters voted on and the results of the vote were as follows:

1. The Company’s shareholders elected the following directors to each serve until the next Annual Meeting of Shareholders or until a successor is duly elected and qualified.
 
      Number of Votes
 
      For       Against       Abstain       Broker Non-Votes
Amy L. Banse   85,257,601     1,090,707     260,962     18,222,827  
Julia Denman 85,663,547 679,455 266,267 18,222,827
Spencer C. Fleischer 84,833,382 1,491,959 283,930 18,222,827
Esther Lee 85,460,628 888,455 260,187 18,222,827
A.D. David Mackay 85,544,613 790,520 274,137 18,222,827
Paul Parker 85,692,013 641,810 275,448 18,222,827
Stephanie Plaines 85,600,327 743,060 265,883 18,222,827
Linda Rendle 85,542,167 802,236 264,867 18,222,827
Matthew J. Shattock 84,014,161 2,326,236 268,874 18,222,827
Kathryn Tesija 85,386,553 959,875 262,842 18,222,827
Russell J. Weiner 85,520,082 803,127 286,061 18,222,827
Christopher J. Williams 85,277,028 1,054,292 277,951 18,222,827
 
2. The Company’s shareholders voted for (on an advisory basis) the approval of the compensation of the Company’s named executive officers.
 
Number of Votes
For       Against       Abstain       Broker Non-Votes
80,870,158 5,199,569 539,543 18,222,827
 
3. The Company’s shareholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2023.
 
Number of Votes
For       Against       Abstain       Broker Non-Votes
102,642,634 1,870,724 318,740 0

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

See the Exhibit Index below.

EXHIBIT INDEX

Exhibit Description
 
104       Cover Page Interactive Data File (embedded within the Inline XBRL document)
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CLOROX COMPANY
 
Date: November 17, 2022 By:          /s/ Angela Hilt
Angela Hilt
Executive Vice President – Chief Legal Officer